Screening compound: InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H

Screening compound: InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H
Screening compound: InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P616-0011

Molecular Formula

C12H7N5O2 (C12 H7 N5 O2)

Compound Name

5-(furan-3-yl)-3-{[1,2,4]triazolo[4,3-a]pyridin-6-yl}-1,2,4-oxadiazole

IUPAC name

5-(furan-3-yl)-3-{[124]triazolo[43-a]pyridin-6-yl}-124-oxadiazole

SMILES

c1cocc1-c1nc(-c(cc2)cn3c2nnc3)no1

InChI

InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H

InChI Key

DOVKEAROYMXORU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27606684

InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H?
Check Price and Availability of InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C12H7N5O2/c1-2-10-15-13-7-17(10)5-8(1)11-14-12(19-16-11)9-3-4-18-6-9/h1-7H available by request